tuneTypical Dose
Often around 1 x 10^10 to 1 x 10^11 inactivated cells/day for heat-killed bacterial products
Microbiome Modulator
Postbiotics
Inanimate microorganism preparations (class term, no single species)
Evidence TierCWADA NOT PROHIBITED
watchEffect Window
Usually 4-12 weeks depending on endpoint.
check_circleCompliance
WADA NOT PROHIBITED
Overview
Clinical Summary
Postbiotics are non-living microbial preparations that can influence gut-immune signaling without requiring live organisms.
Early human evidence suggests some postbiotic and paraprobiotic products can modestly improve subjective sleep quality and selected stress-linked outcomes, but the evidence remains product-specific rather than class-wide. GI effects are mixed, with a large IBS trial showing no overall primary-endpoint benefit. Most claims still depend on strain, manufacturing method, and the exact inactivated preparation used.
Inactivated microbial cells/components can modulate gut-immune-neuroendocrine signaling without live colonization, but outcomes remain strain and process dependent.
Outcomes
What This Is Expected To Influence
Primary Outcomes
- Subjective sleep-quality support (product-specific)
- Selected GI symptom support in targeted subgroups (product-specific)
Secondary Outcomes
- Stress-biomarker modulation in some short trials
- Early metabolic/body-composition signals with specific strains
Safety
Contraindications and Interactions
Contraindications
- Product-component allergy
- Pregnancy/breastfeeding without product-specific evidence
- Severe medical instability without clinician oversight
Side effects
- Mild GI discomfort
- Transient stool-pattern changes
- Limited long-term data in special populations
Interactions
- No strong class-wide drug interaction profile established
- Symptom-attribution challenges when layered onto complex GI regimens
- Confounding overlap with simultaneous probiotic/prebiotic initiation
Avoid if
- Severe immunocompromise unless clinician supervised
- Pediatric use without pediatric evidence
- Multi-supplement starts where attribution is impossible
Evidence
Study-level References
postbiotics-SRC-001Consensus statement.
Sourceopen_in_newSalminen S, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-667. doi:10.1038/s41575-021-00440-6. PMID:33948025.
Population: Expert panel review of definitions, scope, mechanisms, and evidence requirements.
Dose protocol: Not applicable.
Key findings: Defines postbiotics and evidence expectations for health claims.
Notes: Not an efficacy trial. Critical for taxonomy/regulatory clarity.
Paper content
Defines postbiotics and evidence expectations for health claims.
postbiotics-SRC-002Phase IV randomized, double-blind, placebo-controlled, multicenter trial.
Sourceopen_in_newMack I, et al. A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. Clin Gastroenterol Hepatol. 2022;20(5):1039-1047.e9. doi:10.1016/j.cgh.2021.06.028. PMID:34214682.
Population: 389 adults with IBS (Rome III), mixed IBS subtypes.
Dose protocol: Nonviable lysate vs placebo for 26 weeks.
Key findings: Null on primary overall IBS endpoints. Possible IBS-D signal.
Notes: Strong design and sample size. Subtype findings exploratory.
Paper content
Null on primary overall IBS endpoints; possible IBS-D signal.
postbiotics-SRC-003Systematic review and meta-analysis.
Sourceopen_in_newIrwin C, et al. Effects of probiotics and paraprobiotics on subjective and objective sleep metrics: a systematic review and meta-analysis. Eur J Clin Nutr. 2020;74(11):1536-1549. doi:10.1038/s41430-020-0656-x. PMID:32433598.
Population: 14 studies (20 trials) in adults.
Dose protocol: Mixed probiotic/paraprobiotic interventions.
Key findings: Subjective PSQI improved. Objective sleep effects less clear.
Notes: Mixed interventions and outcomes. Objective sleep outcomes limited.
Paper content
Subjective PSQI improved; objective sleep effects less clear.
postbiotics-SRC-004Systematic review and meta-analysis (CP2305-focused).
Sourceopen_in_newChu A, et al. Daily consumption of Lactobacillus gasseri CP2305 improves quality of sleep in adults - A systematic literature review and meta-analysis. Clin Nutr. 2023;42(8):1314-1321. doi:10.1016/j.clnu.2023.06.019. PMID:37413809.
Population: 7 studies (6 in quantitative meta-analysis), adults with mild-moderate stress.
Dose protocol: Daily CP2305 intake. Duration varied by trial.
Key findings: Significant PSQI improvement versus controls.
Notes: Product-specific evidence with moderate dataset size.
Paper content
Significant PSQI improvement versus controls.
postbiotics-SRC-005Randomized, double-blind, placebo-controlled, parallel-group trial
Sourceopen_in_newWatanabe T, et al. Effect of Heat-Killed Lactiplantibacillus plantarum SNK12 on Sleep Quality and Stress-Related Neuroendocrine and Inflammatory Biomarkers in Adults. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial. Life (Basel). 2025;16(1):26. doi:10.3390/life16010026. PMID:41598182.
Population: Healthy adults with suboptimal sleep quality.
Dose protocol: Heat-killed SNK12 at >=1 x 10^11 cells/day for 4 weeks.
Key findings: Improved selected sleep indices and reduced cortisol and TNF-alpha over 4 weeks.
Notes: Short, product-specific trial. Useful for stress-linked sleep framing, not class-wide certainty.
Paper content
This 4-week placebo-controlled postbiotic trial reported improvement in two subjective sleep indices and parallel reductions in salivary cortisol and plasma TNF-alpha. The result is useful because it links a heat-killed preparation to both symptom and biomarker changes, but the study was short and product specific.
postbiotics-SRC-006Randomized double-blind placebo-controlled trial
Sourceopen_in_newYamamoto-Yamaya K, et al. The Effect of Heat-Killed Lacticaseibacillus paracasei K71 on Abdominal Fat Reduction: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Trial. J Nutr Sci Vitaminol (Tokyo). 2025;71(5):486-497. doi:10.3177/jnsv.71.486. PMID:41183976.
Population: Adults with BMI >=23 and <30 (n=80)
Dose protocol: 50 mg product (about 1 x 10^11 heat-killed cells) daily for 12 weeks.
Key findings: Mixed findings, with favorable signals in lifestyle-stable subgroup only.
Notes: Overall per-protocol null. Subgroup analyses carry higher bias risk.
Paper content
Favorable adiposity-related changes in lifestyle-stable subgroup
postbiotics-SRC-007Systematic review.
Sourceopen_in_newKerksick CM, et al. It's Dead! Can Postbiotics Really Help Performance and Recovery? A Systematic Review. Nutrients. 2024;16(5):720. doi:10.3390/nu16050720. PMID:38474848.
Population: 9 full manuscripts plus 2 conference abstracts; 477 adults total.
Dose protocol: Mixed postbiotic products over 13 days to 12 weeks.
Key findings: Early positive signals for fatigue/mood/readiness, but insufficient for firm performance claims.
Notes: Small heterogeneous literature with potential conflict-of-interest concerns in field.
Paper content
Early positive signals for fatigue/mood/readiness, but insufficient for firm performance claims.
postbiotics-SRC-008Meta-analysis of randomized controlled trials
Sourceopen_in_newYu B, Wang KY, Wang NR, Zhang L, Zhang JP. Effect of probiotics and paraprobiotics on patients with sleep disorders and sub-healthy sleep conditions: a meta-analysis of randomized controlled trials. Front Neurol. 2024;15:1477533. doi:10.3389/fneur.2024.1477533. PMID:39479010.
Population: Adults with sleep disorders or stress-related sub-healthy sleep conditions.
Dose protocol: Mixed probiotic and paraprobiotic sleep-focused protocols across 11 randomized controlled trials.
Key findings: Meta-analysis found a modest improvement in adult sleep quality, with effects varying by strain choice, baseline health status, and intervention duration.
Notes: Useful for modernizing class-level sleep language, but it blends live and inactivated products so product-specific interpretation still matters.
Paper content
Across 11 randomized trials, probiotics and paraprobiotics produced a modest improvement in adult sleep quality, but the effect varied by baseline health status, strain choice, and intervention duration.